NCT03460977 2026-03-13A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPfizerPhase 1 Recruiting453 enrolled
NCT05914116 2025-11-21A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting862 enrolled
NCT05588609 2025-09-18Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined CancersMerus B.V.Phase 2 Terminated13 enrolled
NCT05057013 2025-08-11A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursCancer Research UKPhase 1/2 Active not recruiting81 enrolled
NCT03568656 2025-08-08Study to Evaluate CCS1477 in Advanced TumoursCellCentric Ltd.Phase 1/2 Completed220 enrolled
NCT04104776 2025-05-15A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasNovartisPhase 1/2 Recruiting275 enrolled
NCT03685591 2024-06-26PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsPfizerPhase 1 Terminated49 enrolled 33 charts